All lobbying filings

JAZZ PHARMACEUTICALS, INC.

Lobbying for JAZZ PHARMACEUTICALS, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $370,000.00 expenses · posted Jul 18, 2025

Official filing document

Bills named in this filing 1

HR 946
ORPHAN Cures Act

Lobbying activity 1

Pharmacy

FDA regulation of CBD Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Farm, Food, and National Security Act Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act Drug safety, prescription drug abuse, value of prescription drugs Changes to the Inflation Reduction Act HR 946: Orphan Cures Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.